MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/mgg3.2071

Медицинская библиотека · Molecular genetics & genomic medicine · 2022

Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.

Negri Serena, De Ponti Elena, Sina Federica Paola, Sala Elena, Dell'Oro Cristina, Roversi Gaia, Lazzarin Sara, Delle Marchette Martina, Inzoli Alesssandra, Toso Claudia, Fumagalli Simona, Campanella Maria, Kotsopoulos Joanne, Fruscio Robert

СтатьяПеревод в очереди

Аннотация

BACKGROUND

BRCA1 and BRCA2 gene mutations are responsible for 5% of breast cancer (BC) and 10-15% of ovarian cancer (EOC). The presence of a germline mutation and therefore the identification of subjects at high risk of developing cancer should ideally precede the onset of the disease, so that appropriate surveillance and risk-reducing treatments can be proposed. In this study, we revisited the family history (FH) of women who tested positive for BRCA mutations after being diagnosed with BC or EOC.

METHODS

The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines®), and the Italian Association of Medical Oncology (AIOM) guidelines were applied to the FH of 157 women who were referred to San Gerardo Hospital for genetic counseling.

RESULTS

Almost 85% of women had an FH of BRCA-related cancer. 63.7% and 52.2% of women could have undergone genetic testing according to NCCN and AIOM testing criteria (p < .05) before tumor diagnosis. An FH of EOC was the most frequent NCCN criterion, followed by BC diagnosed <45 years old. Sixty-five percent of deceased women could have undergone genetic testing before developing cancer.

CONCLUSIONS

FH is a powerful tool to identify high-risk individuals eligible for genetic counseling and testing. Testing of healthy individuals should be considered when an appropriately affected family member is unavailable for testing.

Для цитирования: Negri Serena, De Ponti Elena, Sina Federica Paola, Sala Elena, Dell'Oro Cristina, Roversi Gaia, Lazzarin Sara, Delle Marchette Martina, Inzoli Alesssandra, Toso Claudia, Fumagalli Simona, Campanella Maria, Kotsopoulos Joanne, Fruscio Robert. Evaluation of family history in individuals with heterozygous BRCA pathogenic variants diagnosed with breast or ovarian cancer in a single center in Italy.. Molecular genetics & genomic medicine. 2022. DOI: 10.1002/mgg3.2071.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.